a public good project by the
Synthesis
Company
of California

© 2026

Christian Peschel | doi.page

0 works0 citations0 h-index

Christian Peschel

Ludwig-Maximilians-Universität München(DE)

Publications by Year

Research Areas

Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Immunotherapy and Immune Responses

Most-Cited Works

→ Improved Survival with Ipilimumab in Patients with Metastatic Melanoma(2010)15,037 cited
→ Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity(2006)837 cited
→ PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial(2007)804 cited
→ Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry(2016)706 cited
→ Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma(2009)542 cited
→ A bioactive designer cytokine for human hematopoietic progenitor cell expansion(1997)536 cited

→ Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey(2015)

536 cited

→ Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production(2009)511 cited

→ Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use(2003)503 cited

→ Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron(2003)471 cited